KD Logo

Sandercock Brett divested 0.23 million US dollars’ worth of Resmed Inc [RMD] stock.

Resmed Inc’s recent filing unveils that its Chief Financial Officer Sandercock Brett unloaded Company’s shares for reported $0.23 million on Jan 08 ’25. In the deal valued at $234.04 per share,1,000 shares were sold. As a result of this transaction, Sandercock Brett now holds 92,864 shares worth roughly $23.01 million.

Then, Sandercock Brett bought 1,000 shares, generating $234,040 in total proceeds.

Before that, FARRELL PETER C sold 2,000 shares. Resmed Inc shares valued at $461,980 were divested by the Director at a price of $230.99 per share. As a result of the transaction, FARRELL PETER C now holds 79,218 shares, worth roughly $19.63 million.

Goldman initiated its Resmed Inc [RMD] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in early January with a ‘”a Neutral”‘ rating. Stifel began covering RMD with “Hold” recommendation on December 13, 2024. Robert W. Baird started covering the stock on September 24, 2024. It rated RMD as “an Outperform”.

Price Performance Review of RMD

On Tuesday, Resmed Inc [NYSE:RMD] saw its stock jump 3.34% to $247.79. Over the last five days, the stock has gained 7.61%. Resmed Inc shares have risen nearly 8.35% since the year began. Nevertheless, the stocks have risen 43.43% over the past one year. While a 52-week high of $260.49 was reached on 01/21/25, a 52-week low of $170.39 was recorded on 01/02/25. SMA at 50 days reached $239.48, while 200 days put it at $223.76.

Levels Of Support And Resistance For RMD Stock

The 24-hour chart illustrates a support level at 244.67, which if violated will result in even more drops to 241.56. On the upside, there is a resistance level at 250.11. A further resistance level may holdings at 252.43. The Relative Strength Index (RSI) on the 14-day chart is 63.92, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 7.50, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 6.72%. Stochastics %K at 93.84% indicates the stock is a selling.

How much short interest is there in Resmed Inc?

A steep rise in short interest was recorded in Resmed Inc stocks on 2024-12-31, growing by 0.37 million shares to a total of 7.91 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 7.54 million shares. There was a rise of 4.69%, which implies that there is a positive sentiment for the stock.

Most Popular